Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Del Prato, S.
Right arrow Articles by Penno, G.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

Review: The importance of effective early phase insulin secretion

Stefano Del Prato

Department of Endocrinology & Metabolism, Section of Diabetes, Ospedale Cisanello, Via Paradisa, 2, 56124 Pisa, Italy, delprato{at}immr.med.unipi.it

Roberto Miccoli

Giuseppe Penno

Low insulin sensitivity and a selective loss of acute insulin release identify those individuals at the highest risk of developing type 2 diabetes. Normally, the rapid release of insulin after the ingestion of a meal is critical for post-prandial glucose regulation as first-phase insulin modulates suppression of endogenous glucose production and, therefore, limits meal-related plasma glucose excursions. The loss of first-phase insulin secretion contributes to the development of glucose intolerance. Indeed, postprandial hyperglycaemia represents the first and more evident perturbation of glucose homeostasis in about 60% of newly diagnosed type 2 diabetic patients. In these individuals, restoration of first-phase insulin secretion may result in more efficient inhibition of hepatic glucose production and improved glucose tolerance. In the light of these considerations, therapeutic intervention either alone or in combination with improvement of insulin resistance should be considered early in the course of the disease to prevent excessively rapid deterioration of glycaemic control.

Key Words: type 2 diabetes • impaired acute insulin secretion • insulin resistance.

References

  • Del Prato S., Maran A., Beck-Nielsen H. The plurimetabolic syndrome in the European Population: the experience of the European Group on Insulin Resistance (EGIR). Insulin Resistance, Metabolic Diseases and Diabetic Complications. In: Crepaldi G, Tiengo A, Del Prato S. eds. Excerpta Medica. International Congress Series 1177, Internal Medicine. Elsevier, Amsterdam, 1999:25-30.
  • Haffner SM, Miettinen H., Gaskill SP, Stern M. Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance. Diabetologia 1996;39:1201-07.[Web of Science][Medline] [Order article via Infotrieve]
  • Bonora E., Formentini G., Calcaterra F. et al. HOMA-Estimated Insulin Resistance is an Independent Predictor of Cardiovascular Disease in Type 2 Diabetic Subjects: Prospective data from the Verona Diabetes Complications Study. Diabetes Care 2002;25:1135-41.[Abstract/Free Full Text]
  • Brunzell JD, Robertson RP, Lerner RL et al. Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab 1976;42:222-9.[Abstract/Free Full Text]
  • Del Prato S., Ferrannini E., DeFronzo RA Evaluation of Insulin Sensitivity in Man. In: Methods in Diabetes Research, Vol. II, Clarke WL, Larner J. Pohl SL eds, J. Wiley & Sons, 1986:35-76.
  • Toffolo G., Bergman RN, Finegood DT, Bowden CR, Cobelli C. Quantitative estimation of beta cell sensitivity to glucose in the intact organism: a minimal model of insulin kinetics in the dog. Diabetes 1980;29:979-90.[Abstract]
  • Yoneda H., Ikegami H., Yamamoto et al. Analysis of early-phase insulin responses in nonobese subjects with mild glucose intolerance. Diabetes Care 1992;15:1517-21.[Abstract]
  • Cretti A., Lehtovirta M., Bonora E. et al. Assessment of beta-cell function secretion. Eur J Clin Invest 2001;31:405-16. during the oral glucose tolerance test by a minimal model of insulin secretion, Eur J Clin Invest 2001;31:405-16[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Mari A. Mathematical modeling in glucose metabolism and insulin secretion. Curr Opin Clin Nutr Metab Care 2002;5:495-501.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Holman RR Assessing the potential for alpha-glucosidase inhibitors in prediabetic states. Diabetes Res Clin Pract 1998;40(suppl):S21-S25.[Web of Science][Medline] [Order article via Infotrieve]
  • Larsson H., Ahren B. Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagons secretion in postmenopausal women with impaired glucose tolerance. Diabetes Care 2000;23:650-7.[Abstract/Free Full Text]
  • Haffner SM, Mykkanen L., Festa A., Burke JP, Stern MP Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state. Circulation 2000;101:975-80.[Abstract/Free Full Text]
  • Lundgren H., Bengtsson C., Blohmè G., Lapidus L., Waldeström J. Fasting serum insulin concentration and early insulin response as risk determinants for developing diabetes. Diabet Med 1990;7:407-13.[Web of Science][Medline] [Order article via Infotrieve]
  • Kosaka K., Kuzuya T., Hagura R., Yoshinaga H. Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus. Diabet Med 1996;13:S109-S119.[Web of Science][Medline] [Order article via Infotrieve]
  • Hanson RL, Pratley RE, Bogardus C. et al. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 2000;151:190-8.[Abstract/Free Full Text]
  • Del Prato S., Marchetti P., Bonadonna RC Phasic insulin release and metabolic regulation in type 2 diabetes. Diabetes 2002;51(suppl 1):S109-S116.[Abstract/Free Full Text]
  • Weyer C., Bogardus C., Mott DM, Pratley RE The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999;104:787-94.[Web of Science][Medline] [Order article via Infotrieve]
  • Weyer C., Tataranni PA, Bogardus C., Prately RE Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of Type 2 diabetes development. Diabetes Care 2001;24:89-94.[Abstract/Free Full Text]
  • Ferrannini E., Gastaldelli A., Miyazaki Y., Matsuda M., Mari A., DeFronzo RA Beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab 2005;90:493-500.[Abstract/Free Full Text]
  • Gastaldelli A., Ferrannini E., Miyazaki Y., Matsuda M., DeFronzo RA San Antonio metabolism study. Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia 2004;47:31-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Bruce DG, Storlien LH, Furler SM, Chisholm DJ Cephalic phase metabolic responses in normal weight adults. Metabolism 1987;36:721-5.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Mitrakou A., Kelley D., Mokan M. et al. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 1992;326:22-9.[Abstract]
  • Cherrington AD, Sindelar D., Edgerton D., Steiner K., McGuinness OP Physiological consequences of phasic insulin release in the normal animal. Diabetes 2002;51(suppl 1):S103-S108.[Abstract/Free Full Text]
  • Luzi L., DeFronzo RA Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans. Am J Physiol 1989;257:E241-E246.[Web of Science][Medline] [Order article via Infotrieve]
  • Calles-Escandon J., Robbins DC Loss of early phase of insulin release in humans impairs gucose tolerance and blunts thermic effect of glucose. Diabetes 1987;36:1167-72.[Abstract]
  • Basu A., Alzaid A., Dinneen S., Caumo A., Cobelli C., Rizza RA Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of differing degrees of insulin resistance. J Clin Invest 1986;97:2351-61.[CrossRef]
  • Sartor G., Schersten B., Carlstrom S., Melander A., Norden A., Persson G. Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation. Diabetes 1980;29:41-9.[Abstract]
  • Knowler WC, Barrett-Connor E., Fowler SE et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.[Abstract/Free Full Text]
  • Tuomilehto J., Lindstrom J., Eriksson JG et al. Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50[Abstract/Free Full Text]
  • Del Prato S., Leonetti F., Simonson DC, Sheean P., Matsuda M., DeFronzo RA Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man. Diabetologia 1994;37:1025-35.[Web of Science][Medline] [Order article via Infotrieve]
  • Kashyap S., Belfort R., Gastaldelli A. et al. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 2003;52:2461-74.[Abstract/Free Full Text]
  • Bruce DG, Chisholm DJ, Storlien LH, Kraegen EW Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes. Diabetes 1988;37:736-44.[Abstract]
  • Bruttomesso D., Pianta A., Mari A. et al. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes 1999;48:99-105.[Abstract]
  • Hosker JP, Rudenski AS, Burnett MA et al. Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy. Metabolism 1989;38:767-72.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Juhl CB, Porksen N., Pincus SM, Hansen AP, Veldhuis JD, Schmitz O. Acute and short-term administration of a sulfonylurea (gliclazide) increases pulsatile insulin secretion in type 2 diabetes. Diabetes 2001;50:1778-84.[Abstract/Free Full Text]
  • Dornhorst A. Insulinotropic meglitinide analogues. Lancet 2001;358:1709-16.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Holst JJ, Gromada J. Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans. Am J Physiol Endocrinol Metab 2004;287:E199-E206.[Abstract/Free Full Text]
  • Rachman J. Potential therapies mimicking the effects of glucagon-like peptide-1 for the treatment of type 2 diabetes. Diabet Med 2004;21 (suppl 1):18-20.[Web of Science][Medline] [Order article via Infotrieve]
  • Wiedeman PE, Trevillyan JM Dipeptidyl peptidase IV inhibitors for the treatment of impaired glucose tolerance and type 2 diabetes. Curr Opin Investig Drugs 2003;4:412-20.[Medline] [Order article via Infotrieve]

The British Journal of Diabetes & Vascular Disease, Vol. 5, No. 4, 198-202 (2005)
DOI: 10.1177/14746514050050040401
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 British Journal of Diabetes & Vascular DiseaseHome page
G. Alberti
Tight glycaemic control: the key to improving the management of type 2 diabetes
The British Journal of Diabetes & Vascular Disease, July 1, 2005; 5(4): 184 - 185.
[PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Del Prato, S.
Right arrow Articles by Penno, G.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?